Amedeo Smart

Free Medical Literature Service


 

Amedeo

Colorectal Neoplasms

  Free Subscription

Articles published in
Oncogene
    May 2018
  1. KNICKELBEIN K, Tong J, Chen D, Wang YJ, et al
    Restoring PUMA induction overcomes KRAS-mediated resistance to anti-EGFR antibodies in colorectal cancer.
    Oncogene. 2018 May 14. pii: 10.1038/s41388-018-0289.
    >> Share

    April 2018
  2. COANT N, Garcia-Barros M, Zhang Q, Obeid LM, et al
    AKT as a key target for growth promoting functions of neutral ceramidase in colon cancer cells.
    Oncogene. 2018 Apr 17. pii: 10.1038/s41388-018-0236.
    >> Share

  3. JUNG JH, Jung DB, Kim H, Lee H, et al
    Zinc finger protein 746 promotes colorectal cancer progression via c-Myc stability mediated by glycogen synthase kinase 3beta and F-box and WD repeat domain-containing 7.
    Oncogene. 2018 Apr 9. pii: 10.1038/s41388-018-0225.
    >> Share

    March 2018
  4. ZHANG Y, Wang S, Kang W, Liu C, et al
    CREPT facilitates colorectal cancer growth through inducing Wnt/beta-catenin pathway by enhancing p300-mediated beta-catenin acetylation.
    Oncogene. 2018 Mar 22. pii: 10.1038/s41388-018-0161.
    >> Share

  5. CHU PC, Lin PC, Wu HY, Lin KT, et al
    Mutant KRAS promotes liver metastasis of colorectal cancer, in part, by upregulating the MEK-Sp1-DNMT1-miR-137-YB-1-IGF-IR signaling pathway.
    Oncogene. 2018 Mar 21. pii: 10.1038/s41388-018-0222.
    >> Share

  6. SAPONARO C, Sergio S, Coluccia A, De Luca M, et al
    beta-catenin knockdown promotes NHERF1-mediated survival of colorectal cancer cells: implications for a double-targeted therapy.
    Oncogene. 2018 Mar 19. pii: 10.1038/s41388-018-0170.
    >> Share

  7. TANG J, Chen H, Wong CC, Liu D, et al
    DEAD-box helicase 27 promotes colorectal cancer growth and metastasis and predicts poor survival in CRC patients.
    Oncogene. 2018 Mar 14. pii: 10.1038/s41388-018-0196.
    >> Share

    February 2018
  8. ROMANO G, Chagani S, Kwong LN
    The path to metastatic mouse models of colorectal cancer.
    Oncogene. 2018 Feb 21. pii: 10.1038/s41388-018-0155.
    >> Share

    January 2018
  9. SHEN L, Qu X, Li H, Xu C, et al
    NDRG2 facilitates colorectal cancer differentiation through the regulation of Skp2-p21/p27 axis.
    Oncogene. 2018 Jan 18. pii: 10.1038/s41388-017-0118.
    >> Share

  10. SOLOMON H, Dinowitz N, Pateras IS, Cooks T, et al
    Mutant p53 gain of function underlies high expression levels of colorectal cancer stem cells markers.
    Oncogene. 2018 Jan 18. pii: 10.1038/s41388-017-0060.
    >> Share

  11. HERR R, Halbach S, Heizmann M, Busch H, et al
    BRAF inhibition upregulates a variety of receptor tyrosine kinases and their downstream effector Gab2 in colorectal cancer cell lines.
    Oncogene. 2018 Jan 12. pii: 10.1038/s41388-017-0063.
    >> Share

    December 2017
  12. OMOTO T, Kim-Kaneyama JR, Lei XF, Orimo A, et al
    The impact of stromal Hic-5 on the tumorigenesis of colorectal cancer through lysyl oxidase induction and stromal remodeling.
    Oncogene. 2017 Dec 15. pii: 10.1038/s41388-017-0033.
    >> Share

  13. BLOMME A, Van Simaeys G, Doumont G, Costanza B, et al
    Murine stroma adopts a human-like metabolic phenotype in the PDX model of colorectal cancer and liver metastases.
    Oncogene. 2017 Dec 15. pii: 10.1038/s41388-017-0018.
    >> Share

  14. LEE SH, Yu J, Hwang GH, Kim S, et al
    CUT-PCR: CRISPR-mediated, ultrasensitive detection of target DNA using PCR.
    Oncogene. 2017;36:6823-6829.
    >> Share

    November 2017
  15. HATA AN, Rowley S, Archibald HL, Gomez-Caraballo M, et al
    Synergistic activity and heterogeneous acquired resistance of combined MDM2 and MEK inhibition in KRAS mutant cancers.
    Oncogene. 2017;36:6581-6591.
    >> Share

  16. LEE JH, Han YS, Yoon YM, Yun CW, et al
    Role of HSPA1L as a cellular prion protein stabilizer in tumor progression via HIF-1alpha/GP78 axis.
    Oncogene. 2017;36:6555-6567.
    >> Share

  17. WANG Q, Zhu J, Wang YW, Dai Y, et al
    Tumor suppressor Pdcd4 attenuates Sin1 translation to inhibit invasion in colon carcinoma.
    Oncogene. 2017;36:6225-6234.
    >> Share

  18. TRINIDAD AG, Whalley N, Rowlinson R, Delpuech O, et al
    Pyruvate dehydrogenase kinase 4 exhibits a novel role in the activation of mutant KRAS, regulating cell growth in lung and colorectal tumour cells.
    Oncogene. 2017;36:6164-6176.
    >> Share

    October 2017
  19. SCHROYER AL, Stimes NW, Abi Saab WF, Chadee DN, et al
    MLK3 phosphorylation by ERK1/2 is required for oxidative stress-induced invasion of colorectal cancer cells.
    Oncogene. 2017 Oct 30. doi: 10.1038/onc.2017.
    >> Share

  20. BENTHANI FA, Herrmann D, Tran PN, Pangon L, et al
    'MCC' protein interacts with E-cadherin and beta-catenin strengthening cell-cell adhesion of HCT116 colon cancer cells.
    Oncogene. 2017 Oct 16. doi: 10.1038/onc.2017.
    >> Share

  21. WEISENBERGER DJ, Liang G, Lenz HJ
    DNA methylation aberrancies delineate clinically distinct subsets of colorectal cancer and provide novel targets for epigenetic therapies.
    Oncogene. 2017 Oct 9. doi: 10.1038/onc.2017.
    >> Share

  22. WANG LF, Liu YS, Yang B, Li P, et al
    The extracellular matrix protein mindin attenuates colon cancer progression by blocking angiogenesis via Egr-1-mediated regulation.
    Oncogene. 2017 Oct 9. doi: 10.1038/onc.2017.
    >> Share

    September 2017
  23. FU LN, Wang YQ, Tan J, Xu J, et al
    Role of JMJD2B in colon cancer cell survival under glucose-deprived conditions and the underlying mechanisms.
    Oncogene. 2017 Sep 25. doi: 10.1038/onc.2017.
    >> Share

  24. LIU L, Wong CC, Gong B, Yu J, et al
    Functional significance and therapeutic implication of ring-type E3 ligases in colorectal cancer.
    Oncogene. 2017 Sep 18. doi: 10.1038/onc.2017.
    >> Share

    August 2017
  25. WANG X, Haring MF, Rathjen T, Lockhart SM, et al
    Insulin resistance in vascular endothelial cells promotes intestinal tumour formation.
    Oncogene. 2017;36:4987-4996.
    >> Share

  26. HANLEY MP, Hahn MA, Li AX, Wu X, et al
    Genome-wide DNA methylation profiling reveals cancer-associated changes within early colonic neoplasia.
    Oncogene. 2017;36:5035-5044.
    >> Share

  27. DIEHL K, Dinges LA, Helm O, Ammar N, et al
    Nuclear factor E2-related factor-2 has a differential impact on MCT1 and MCT4 lactate carrier expression in colonic epithelial cells: a condition favoring metabolic symbiosis between colorectal cancer and stromal cells.
    Oncogene. 2017 Aug 28. doi: 10.1038/onc.2017.
    >> Share

  28. WANG G, Fu Y, Yang X, Luo X, et al
    Brg-1 targeting of novel miR550a-5p/RNF43/Wnt signaling axis regulates colorectal cancer metastasis.
    Oncogene. 2017 Aug 28. doi: 10.1038/onc.2017.
    >> Share

  29. RUAN H, Zhan YY, Hou J, Xu B, et al
    Berberine binds RXRalpha to suppress beta-catenin signaling in colon cancer cells.
    Oncogene. 2017 Aug 28. doi: 10.1038/onc.2017.
    >> Share

  30. LI XX, Zhang HS, Xu YM, Zhang RJ, et al
    Knockdown of IRE1alpha inhibits colonic tumorigenesis through decreasing beta-catenin and IRE1alpha targeting suppresses colon cancer cells.
    Oncogene. 2017 Aug 21. doi: 10.1038/onc.2017.
    >> Share

  31. SUMNER ET, Chawla AT, Cororaton AD, Koblinski JE, et al
    Transforming activity and therapeutic targeting of C-terminal-binding protein 2 in Apc-mutated neoplasia.
    Oncogene. 2017;36:4810-4816.
    >> Share

  32. AHMAD R, Kumar B, Chen Z, Chen X, et al
    Loss of claudin-3 expression induces IL6/gp130/Stat3 signaling to promote colon cancer malignancy by hyperactivating Wnt/beta-catenin signaling.
    Oncogene. 2017 Aug 7. doi: 10.1038/onc.2017.
    >> Share

    July 2017
  33. YE J, Wei X, Shang Y, Pan Q, et al
    Core 3 mucin-type O-glycan restoration in colorectal cancer cells promotes MUC1/p53/miR-200c-dependent epithelial identity.
    Oncogene. 2017 Jul 24. doi: 10.1038/onc.2017.
    >> Share

  34. MA X, Meng Z, Jin L, Xiao Z, et al
    CAMK2gamma in intestinal epithelial cells modulates colitis-associated colorectal carcinogenesis via enhancing STAT3 activation.
    Oncogene. 2017;36:4060-4071.
    >> Share

  35. TSOI H, Lam KC, Dong Y, Zhang X, et al
    Pre-45s rRNA promotes colon cancer and is associated with poor survival of CRC patients.
    Oncogene. 2017 Jul 10. doi: 10.1038/onc.2017.
    >> Share

  36. JU HQ, Lu YX, Wu QN, Liu J, et al
    Disrupting G6PD-mediated Redox homeostasis enhances chemosensitivity in colorectal cancer.
    Oncogene. 2017 Jul 10. doi: 10.1038/onc.2017.
    >> Share

  37. HARDBOWER DM, Coburn LA, Asim M, Singh K, et al
    EGFR-mediated macrophage activation promotes colitis-associated tumorigenesis.
    Oncogene. 2017;36:3807-3819.
    >> Share

    June 2017
  38. LI Y, Zhou T, Wang Y, Ning C, et al
    The protumorigenic potential of FTY720 by promoting extramedullary hematopoiesis and MDSC accumulation.
    Oncogene. 2017;36:3760-3771.
    >> Share

  39. ROS S, Floter J, Kaymak I, Da Costa C, et al
    6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells.
    Oncogene. 2017;36:3287-3299.
    >> Share

    May 2017
  40. KRAMER N, Schmollerl J, Unger C, Nivarthi H, et al
    Autocrine WNT2 signaling in fibroblasts promotes colorectal cancer progression.
    Oncogene. 2017 May 29. doi: 10.1038/onc.2017.
    >> Share

  41. UNGER C, Kramer N, Unterleuthner D, Scherzer M, et al
    Stromal-derived IGF2 promotes colon cancer progression via paracrine and autocrine mechanisms.
    Oncogene. 2017 May 22. doi: 10.1038/onc.2017.
    >> Share

  42. PEK M, Yatim SMJM, Chen Y, Li J, et al
    Oncogenic KRAS-associated gene signature defines co-targeting of CDK4/6 and MEK as a viable therapeutic strategy in colorectal cancer.
    Oncogene. 2017 May 1. doi: 10.1038/onc.2017.
    >> Share

    April 2017
  43. MERTZ TM, Baranovskiy AG, Wang J, Tahirov TH, et al
    Nucleotide selectivity defect and mutator phenotype conferred by a colon cancer-associated DNA polymerase delta mutation in human cells.
    Oncogene. 2017 Apr 3. doi: 10.1038/onc.2017.
    >> Share

    March 2017
  44. MI L, Zhu F, Yang X, Lu J, et al
    The metastatic suppressor NDRG1 inhibits EMT, migration and invasion through interaction and promotion of caveolin-1 ubiquitylation in human colorectal cancer cells.
    Oncogene. 2017 Mar 27. doi: 10.1038/onc.2017.
    >> Share

  45. ZHANG Q, Wei T, Shim K, Wright K, et al
    Atypical role of sprouty in colorectal cancer: sprouty repression inhibits epithelial-mesenchymal transition.
    Oncogene. 2017 Mar 13. doi: 10.1038/onc.2017.
    >> Share

    January 2017
  46. YI H, Geng L, Black A, Talmon G, et al
    The miR-487b-3p/GRM3/TGFbeta signaling axis is an important regulator of colon cancer tumorigenesis.
    Oncogene. 2017 Jan 23. doi: 10.1038/onc.2016.
    >> Share

  47. GUEGUINOU M, Crottes D, Chantome A, Rapetti-Mauss R, et al
    The SigmaR1 chaperone drives breast and colorectal cancer cell migration by tuning SK3-dependent Ca2+ homeostasis.
    Oncogene. 2017 Jan 23. doi: 10.1038/onc.2016.
    >> Share

  48. AGARWAL E, Robb CM, Smith LM, Brattain MG, et al
    Role of Akt2 in regulation of metastasis suppressor 1 expression and colorectal cancer metastasis.
    Oncogene. 2017 Jan 9. doi: 10.1038/onc.2016.
    >> Share

    December 2016
  49. WANG T, Xu X, Xu Q, Ren J, et al
    miR-19a promotes colitis-associated colorectal cancer by regulating tumor necrosis factor alpha-induced protein 3-NF-kappaB feedback loops.
    Oncogene. 2016 Dec 19. doi: 10.1038/onc.2016.
    >> Share

    November 2016
  50. JIA H, Song L, Cong Q, Wang J, et al
    The LIM protein AJUBA promotes colorectal cancer cell survival through suppression of JAK1/STAT1/IFIT2 network.
    Oncogene. 2016 Nov 28. doi: 10.1038/onc.2016.
    >> Share

  51. BERTHENET K, Bokhari A, Lagrange A, Marcion G, et al
    HSP110 promotes colorectal cancer growth through STAT3 activation.
    Oncogene. 2016 Nov 7. doi: 10.1038/onc.2016.
    >> Share

    October 2016
  52. MATSUMURA K, Kawasaki Y, Miyamoto M, Kamoshida Y, et al
    The novel G-quadruplex-containing long non-coding RNA GSEC antagonizes DHX36 and modulates colon cancer cell migration.
    Oncogene. 2016 Oct 31. doi: 10.1038/onc.2016.
    >> Share

    September 2016
  53. CHANDRASINGHE P, Stebbing J, Warusavitarne J
    The MACC1-SPON2 axis: A new biomarker and therapeutic target in colorectal cancer.
    Oncogene. 2016 Sep 26. doi: 10.1038/onc.2016.
    >> Share

  54. HAASE G, Gavert N, Brabletz T, Ben-Ze'ev A, et al
    A point mutation in the extracellular domain of L1 blocks its capacity to confer metastasis in colon cancer cells via CD10.
    Oncogene. 2016 Sep 19. doi: 10.1038/onc.2016.
    >> Share

  55. LIU CC, Cai DL, Sun F, Wu ZH, et al
    FERMT1 mediates epithelial-mesenchymal transition to promote colon cancer metastasis via modulation of beta-catenin transcriptional activity.
    Oncogene. 2016 Sep 19. doi: 10.1038/onc.2016.
    >> Share

  56. WANG J, Zhang B, Wu H, Cai J, et al
    CD51 correlates with the TGF-beta pathway and is a functional marker for colorectal cancer stem cells.
    Oncogene. 2016 Sep 5. doi: 10.1038/onc.2016.
    >> Share

    July 2016
  57. SHENG YH, He Y, Hasnain SZ, Wang R, et al
    MUC13 protects colorectal cancer cells from death by activating the NF-kappaB pathway and is a potential therapeutic target.
    Oncogene. 2016 Jul 11. doi: 10.1038/onc.2016.
    >> Share

  58. TONG J, Tan S, Zou F, Yu J, et al
    FBW7 mutations mediate resistance of colorectal cancer to targeted therapies by blocking Mcl-1 degradation.
    Oncogene. 2016 Jul 11. doi: 10.1038/onc.2016.
    >> Share

  59. ZHANG X, Zhang L, Du Y, Zheng H, et al
    A novel FOXM1 isoform, FOXM1D, promotes epithelial-mesenchymal transition and metastasis through ROCKs activation in colorectal cancer.
    Oncogene. 2016 Jul 11. doi: 10.1038/onc.2016.
    >> Share

  60. ZHONG H, Fazenbaker C, Chen C, Breen S, et al
    Overproduction of IGF-2 drives a subset of colorectal cancer cells, which specifically respond to an anti-IGF therapeutic antibody and combination therapies.
    Oncogene. 2016 Jul 11. doi: 10.1038/onc.2016.
    >> Share

  61. ZHANG Z, Liu X, Feng B, Liu N, et al
    STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer.
    Oncogene. 2016 Jul 4. doi: 10.1038/onc.2016.
    >> Share

    June 2016
  62. PARANG B, Bradley AM, Mittal MK, Short SP, et al
    Myeloid translocation genes differentially regulate colorectal cancer programs.
    Oncogene. 2016 Jun 6. doi: 10.1038/onc.2016.
    >> Share

  63. QU X, Sandmann T, Frierson H Jr, Fu L, et al
    Integrated genomic analysis of colorectal cancer progression reveals activation of EGFR through demethylation of the EREG promoter.
    Oncogene. 2016 Jun 6. doi: 10.1038/onc.2016.
    >> Share

    May 2016
  64. FESSLER E, Jansen M, De Sousa E Melo F, Zhao L, et al
    A multidimensional network approach reveals microRNAs as determinants of the mesenchymal colorectal cancer subtype.
    Oncogene. 2016 May 9. doi: 10.1038/onc.2016.
    >> Share

    February 2016
  65. YIN N, Qi X, Tsai S, Lu Y, et al
    p38gamma MAPK is required for inflammation-associated colon tumorigenesis.
    Oncogene. 2016;35:1039-48.
    >> Share

    January 2016
  66. ONEYAMA C, Yoshikawa Y, Ninomiya Y, Iino T, et al
    Fer tyrosine kinase oligomer mediates and amplifies Src-induced tumor progression.
    Oncogene. 2016;35:501-12.
    >> Share

  67. TENG Y, Ren X, Li H, Shull A, et al
    Mitochondrial ATAD3A combines with GRP78 to regulate the WASF3 metastasis-promoting protein.
    Oncogene. 2016;35:333-43.
    >> Share

  68. PNG CW, Weerasooriya M, Guo J, James SJ, et al
    DUSP10 regulates intestinal epithelial cell growth and colorectal tumorigenesis.
    Oncogene. 2016;35:206-17.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016